MX Orthopedics’ compression staple receives FDA clearance: 5 facts

MX Orthopedics received FDA clearance for its patent-pending dynaMX Compression Staple featuring malleable nitinol technology.

Advertisement

Here are five facts:

 

1. The dynaMX Compression Staple is initially indicated for fracture and osteotomy fixation of the hand and foot; joint arthrodesis of the hand and foot; and fixation of proximal tibial metaphysis osteotomy.  

 

2. The staple combines superelastic legs for compression with a malleable bridge that can be contoured to match the patient’s anatomy.

 

3. The staple is a part of MX Orthopedics’ fracture fixation portfolio.

 

4. MX Orthopedics is a privately held medical company focusing on creating orthopedic implants manufactured from superelastic Nitinol.

 

More articles on devices:
15 things to know about Zimmer Biomet
DePuy Synthes invests $60M in expanded manufacturing plant in Ireland: 4 things to know
3D Systems named to top 50 ‘smartest companies’ list: 5 observations

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.